Loading clinical trials...
Loading clinical trials...
Comparison of Alfredson Eccentric and Silbernagel Concentric-eccentric Therapeutical Protocol in Competitive Athletes With Chronic Achilles Tendinopathy
A 6-week randomized clinical trial (RCT) with a 46-week follow-up compared the effect of Alfredson and Silbernagel eccentric programs for the treatment of AT. The primary outcome was a change in the Victorian Institute of Sport Assessment - Achilles (VISA-A) scale from baseline to 12 months. The study was approved by the Ethics Committee of the Faculty of Physical Education and Sport, Charles University (Project number: 254/2021). All participants provided written informed consent before participation.
Age
18 - 40 years
Sex
ALL
Healthy Volunteers
No
Faculty of Physical Education and Sport at Charles University
Prague, Prague 6, Czechia
Start Date
December 2, 2022
Primary Completion Date
December 2, 2024
Completion Date
December 30, 2024
Last Updated
February 7, 2024
40
ESTIMATED participants
Alfredson protocol
OTHER
Silbernagel protocol
OTHER
Lead Sponsor
Charles University, Czech Republic
NCT06593912
NCT05464498
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions